Biosecurity Analyst
Biosecurity Analyst

Biography

Lane Warmbrod is a research analyst specializing in biological and chemical weapons nonproliferation at Pacific Northwest National Laboratory (PNNL). Her work primarily focuses on improving national and global security by maximizing the benefits of life science research while minimizing risks to safety and security in an equitable manner. 

During the COVID-19 pandemic, Warmbrod was seconded to the World Health Organization to support their response to the pandemic. There, she was a member of the Incident Management Support Team and collected and analyzed data to inform response and contribute to guidance development. Warmbrod also served as the pandemic health advisor to Washington State Governor Jay Inslee during the pandemic. 

Previously, Warmbrod worked at the Johns Hopkins Center for Health Security, where she led projects on biological attribution, the bioeconomy, and the governance of life science research. Prior to Hopkins, she worked at Oak Ridge National Laboratory in the National Security Sciences Directorate, contributing to projects concerning the security of chemical, biological, radiological, and nuclear material, including the development and implementation of training courses and the assessment of foreign nations’ capabilities. 

Lane is currently pursuing a PhD in public health genetics at the University of Washington.

Disciplines and Skills

  • Attribution
  • Biological Nonproliferation
  • Biosafety
  • Biosecurity
  • Epidemiology
  • Microbial Genetics
  • Population Genetics
  • Public Health Emergency Preparedness

Education

  • Master of Public Health, Biosecurity, and Disaster Prep, Saint Louis University
  • Master of Science, Experimental Pathology, The University of Texas Medical Branch
  • Bachelor of Science, Agricultural Biotechnology, University of Kentucky

Affiliations and Professional Service

  • Editor, Health Security
  • Editorial Board, Frontiers in Microbiology

Publications

2022

  • Crook O.M., K.L. Warmbrod, and G. Lipstein, et al. 2022. “Analysis of the first genetic engineering attribution challenge.” Nature Communications, 13, 7374 (2022). https://doi.org/10.1038/s41467-022-35032-8
  • Haines C.A., R.K. Campos, and R.S. Azar, et al. 2022. “Venezuelan Equine Encephalitis Virus V3526 Vaccine RNA-Dependent RNA Polymerase Mutants Increase Vaccine Safety Through Restricted Tissue Tropism in a Mouse Model.” Zoonoses, 2(1). DOI: 10.15212/ZOONOSES-2021-0016
  • Warmbrod K.L., M. Montague, and G.K. Gronvall. 2022. “A Closing Window of Opportunity for Gene Drive Governance in the United States.” Health Security 20(1):3–5. Web.
  • Warmbrod K.L., et al. 2022. “The Need for a Tiered Registry for US Gene Drive Governance.” Health Security, 20(1):43–49. Web.

2021

  • Sell T.K., K.L. Warmbrod, C. Watson, et al. 2021. “Using prediction polling to harness collective intelligence for disease forecasting.” BMC Public Health, 21, 2132 (2021). https://doi.org/10.1186/s12889-021-12083-y
  • Warmbrod K.L., M.G. Montague, and G.K. Gronvall. 2021. “Covid‐19 and the gain of function debates.” EMBO Reports, 22(10). https://doi.org/10.15252/embr.202153739
  • Warmbrod K.L., J. Cole, C.M. Sharkey, A. Sengupta, N. Connell, R. Casagrande, and P. Delarosa. 2021. “Biosafety Professionals: A Role in the Pandemic Response Team.” Health Security. Aug 2021.454-458. http://doi.org/10.1089/HS.2021.0015
  • Ravi S.J., K.L. Warmbrod, A. Barlow, J. Cepeda, Oluwaseun O. Falade-Nwulia, Emily E. Haroz, and T.S. Purnell. 2021. “Why Social Distance Demands Social Justice: Systemic Racism, COVID-19, and Health Security in the United States.” Health Security. Jun 2021.S-1-S-4. http://doi.org/10.1089/hs.2021.0103
  • Crook O.M., K.L. Warmbrod, G. Lipstein, C. Chung, C.W. Bakerlee, T.G. McKelvey, Jr., and W.J. Bradshaw. 2021. “Analysis of the first genetic engineering attribution challenge.” ArXiv, Retrieved from www.scopus.com

2020

  • Hosangadi D., M.P. Shearer, K.L. Warmbrod, L. Kan, M. Cantu, and J.B. Nuzzo. 2020. “Current State of Mass Vaccination Preparedness and Operational Challenges in the United States, 2018-2019.” Health Security. Dec 2020.473-482.http://doi.org/10.1089/hs.2019.0146
  • Biggerstaff M., B.J. Cowling, Z.M. Cucunubá, L. Dinh, N.M. Ferguson, H. Gao, and et al., for the WHO COVID-19 Modelling Parameters Group. 2020. Early insights from statistical and mathematical modeling of key epidemiologic parameters of COVID-19. Emerg Infect Dis. 2020 Nov. https://doi.org/10.3201/eid2611.201074
  • Warmbrod L., J. Revill, and N. Connell. 2020. “Advances in Science and Technology in the Life Sciences and their Implications for Biosecurity and Arms Control.” Geneva, Switzerland: UNIDIR. https://doi.org/10.37559/SecTec/20/01
  • Warmbrod K.L., M. Trotochaud, and G.K. Gronvall. 2020. “Shaping the US Bioeconomy for Future Economic Development and Sustainability.” Health Security. Aug 2020.265-266. http://doi.org/10.1089/hs.2020.0122
  • Warmbrod K.L., M. Trotochaud, and G.K. Gronvall. 2020. “iGEM and the Biotechnology Workforce of the Future.” Health Security. Aug 2020.303-309. http://doi.org/10.1089/hs.2020.0017
  • Hosangadi D., K.L. Warmbrod, E.K. Martin, A. Adalja, A. Cicero, T. Inglesby, C. Watson, M. Watson, and N. Connell. 2020. “Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic.” Vaccine, 38(26):4167–4169. https://doi.org/10.1016/j.vaccine.2020.04.037
  • Warmbrod K.L., M. Montague, N.D. Connell. 2020. “Microbial Forensics: Detection and Characterization in the Twenty-first Century.” In: Martellini, M., Trapp, R. (eds) 21st Century Prometheus. Springer, Cham. https://doi.org/10.1007/978-3-030-28285-1_16

2019

  • Warmbrod L., M. Trotochaud, and N. Connell. 2019. “The Scientist Citizen and the Citizen Scientist: Blurring the Lines,” ILAR Journal, 60(1): 5–8, https://doi.org/10.1093/ilar/ilz022
  • Warmbrod, K.L., E.I. Patterson, T.F. Kautz, A. Stanton, D. Rockx-Brouwer, B.K. Kalveram, K. Khanipov, S. Thangamani, Y. Fofanov, and N.L. Forrester. 2019. “Viral RNA-dependent RNA polymerase mutants display an altered mutation spectrum resulting in attenuation in both Mosquito and vertebrate hosts.” PLOS Pathogens, 15(4). https://doi.org/10.1371/journal.ppat.1007610
  • Patterson, E. I., Warmbrod, K. L., Bouyer, D. H., and N.L. Forrester. 2018. “Evaluation of the inactivation of Venezuelan equine encephalitis virus by several common methods.” Journal of Virological Methods, 254, 31-34. doi:10.1016/j.jviromet.2018.01.009